檢索結果 - Swart, Marelize
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
A Global Health Diagnostic for Personalized Medicine in Resource-Constrained World Settings: A Simple PCR-RFLP Method for Genotyping CYP2B6 g.15582C>T and Science and Policy Releva... 由 Evans, Jonathan, Swart, Marelize, Soko, Nyarai, Wonkam, Ambroise, Huzair, Farah, Dandara, Collet
出版 2015Text -
6
-
7
-
8
-
9
-
10
-
11
Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients 由 Mhandire, Doreen, Lacerda, Miguel, Castel, Sandra, Mhandire, Kudakwashe, Zhou, Danai, Swart, Marelize, Shamu, Tinei, Smith, Peter, Musingwini, Tutsirai, Wiesner, Lubbe, Stray-Pedersen, Babill, Dandara, Collet
出版 2015Text -
12
Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy 由 Collins, Kimberly S., Pratt, Victoria M., Stansberry, Wesley M., Medeiros, Elizabeth B., Kannegolla, Karthik, Swart, Marelize, Skaar, Todd C., Chapman, Arlene B., Decker, Brian S., Moorthi, Ranjani N., Eadon, Michael T.
出版 2019Text -
13
Variants in the CYP2B6 3′UTR alter in vitro and in vivo CYP2B6 activity: potential role of microRNAs 由 Burgess, Kimberly S., Ipe, Joseph, Swart, Marelize, Metzger, Ingrid F., Lu, Jessica, Gufford, Brandon T., Thong, Nancy, Desta, Zeruesenay, Gaedigk, Roger, Pearce, Robin E., Gaedigk, Andrea, Liu, Yunlong, Skaar, Todd C.
出版 2017Text -
14
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-containing Antiretroviral Therapy 由 Desta, Zeruesenay, Gammal, Roseann S., Gong, Li, Whirl-Carrillo, Michelle, Gaur, Aditya H., Sukasem, Chonlaphat, Hockings, Jennifer, Myers, Alan, Swart, Marelize, Tyndale, Rachel, Masimirembwa, Collen, Iwuchukwu, Otito F., Chirwa, Sanika, Lennox, Jeffrey, Gaedigk, Andrea, Klein, Teri, Haas, David W.
出版 2019Text